Skip to main content
Home Biologics
Improved hard-decision decoding for generalized product codes

Improved hard-decision decoding for generalized product codes

Value Proposition When baseband signals are transmitted over communication channels, errors often arise due to noise in the channels. Forward error correction (FEC) is a method of obtaining error control in data transmission, for enhanced…

Read More

Biomarkers to measure patient platelet functional status on aspirin and predict cardiovascular events

Biomarkers to measure patient platelet functional status on aspirin and predict cardiovascular events

Value Proposition Aspirin is the most commonly prescribed anti-platelet medication for prevention of acute coronary syndrome (ACS), which continues to be the leading cause of morbidity and mortality in the U.S. Aspirin has long been…

Read More

Diagnostic and treatment for chronic and acute phase myeloid leukemia

Diagnostic and treatment for chronic and acute phase myeloid leukemia

Value Proposition While cancer therapies have increased survival for many tumor types, the reality is that 50-60% of cancer patients will die from the disease. This highlights a need for the continued search for targeted…

Read More

Compact telescope design for light scanning systems

Compact telescope design for light scanning systems

Value Proposition Scanning laser ophthalmoscopy (SLO) and optical coherence tomography (OCT) are retinal imaging modalities commonly utilized in the clinic to diagnose retinal diseases. SLO is a confocal imaging technique similar to confocal microscopy that…

Read More

Development of novel therapeutic splice-switching oligonucleotides against aggressive prostate cancer

Development of novel therapeutic splice-switching oligonucleotides against aggressive prostate cancer

Value Proposition One in twelve men will be diagnosed with prostate cancer in their lifetime. Castration resistant prostate cancer, which resists traditional hormone therapies and continues to grow and often metastasize with poor survival outcomes,…

Read More

SUMO as a marker of cancer development and target for cancer therapy

SUMO as a marker of cancer development and target for cancer therapy

Value Proposition Cancer therapy remains challenging, and the production of new inhibitor therapies is stinted by the need for clear successful targets that will block tumor cell proliferation. Small ubiquitin-like modifier (SUMO) proteins and the…

Read More

Real-time wireless power transfer control for passive backscattering devices

Real-time wireless power transfer control for passive backscattering devices

A method and apparatus is disclosed herein for real-time wireless power transfer control. In one embodiment, a system comprises: an RF-energy harvesting sensor tag operable to generate a first backscatter signal and at least one…

Read More

GaN-based nitric oxide sensors and methods of making and using the same

GaN-based nitric oxide sensors and methods of making and using the same

Technology GaN-based heterojunction field effect transistor (HFET) sensors are provided with engineered, functional surfaces that act as pseudo-gates, modifying the drain current upon analyte capture. In some embodiments, devices for sensing nitric oxide (NO) species…

Read More

Cell line model of enzalutamide resistant prostate cancer

Cell line model of enzalutamide resistant prostate cancer

Traditionally, AR drug discovery has used both ligand and AR structure-based design, seeking antagonists by classical ligand binding assays or cellular reporter assays that assess functional antagonism of androgen-dependent transcriptional activation. While these largely empirical…

Read More

Cell line model of castration resistant prostate cancer

Cell line model of castration resistant prostate cancer

Traditionally, AR drug discovery has used both ligand and AR structure-based design, seeking antagonists by classical ligand binding assays or cellular reporter assays that assess functional antagonism of androgen-dependent transcriptional activation. While these largely empirical…

Read More

Methods of treatment in diseases treated with therapeutic proteins

Methods of treatment in diseases treated with therapeutic proteins

The present invention relates, in general, to a method of treating patients undergoing enzyme replacement therapy (ERT) or other therapy involving the administration of a proteinaceous therapeutic agent as well gene replacement therapy with non-viral…

Read More

HeLaDuke

HeLaDuke

Cell lines with enhanced sensitivity to estrogens and antiestrogens

Read More

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us